Should we use antidepressant medications for children and adolescents with depressive disorders?

Psychopharmacology Bulletin

Volumn 34, Issue 1, 1998, Pages 35-39

  Birmaher, Boris ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Adolescents; Children; Depression; Pharmacotherapy; Treatment

Indexed keywords

AMITRIPTYLINE; FLUOXETINE; NORTRIPTYLINE; PLACEBO; TRICYCLIC ANTIDEPRESSANT AGENT;

ADOLESCENT; ARTICLE; BEHAVIOR THERAPY; CHILD; CHILD PSYCHIATRY; CLINICAL TRIAL; COGNITIVE THERAPY; DEPRESSION; DYSTHYMIA; HUMAN; MAINTENANCE THERAPY; MANIC DEPRESSIVE PSYCHOSIS; PRIORITY JOURNAL; PSYCHOTHERAPY;

ADOLESCENT; ANTIDEPRESSIVE AGENTS; CHILD; CLINICAL TRIALS; DEPRESSIVE DISORDER; HUMANS;

EID: 0031925433     PISSN: 00485764     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Asarnow, JR; Tompson, M; Hamilton, EB; Goldstein, MJ; and Guthrie, D. Family-expressed emotion, childhood-onset depression, and childhood-onset schizophrenia spectrum disorders: Is expressed emotion a nonspecific correlate of child psychopathology or a specific risk factor for depression? J. Abnorm. Child Psychol. 22:129-146, 1994.
2. Beardslee, WR; Salt, P; Porterfield, K; Rothberg, PC; van de Velde, P; Swatling, S; Hoke, L; Moilanen, DL; and Whelock, I. Comparison of preventive interventions for families with parental affective disorder. J. Am. Acad. Child Adolesc. Psychiatry 32:254-263, 1993.
3. Beck, AT; Ward, C; Mendelson, M; Mock, J; and Erbaugh, J. An inventory for measuring depression. Arch. Gen. Psychiatry 4:561-571, 1961.
4. Birmaher, B; Ryan, ND; Williamson, DE; Brent, DA; and Kaufman, J. Childhood and adolescent depression: A review of the past 10 years - Part II. J. Am. Acad. Child Adolesc. Psychiatry 35:1575-1583, 1996a.
5. Birmaher, B; Ryan, ND; Williamson, D; Brent, D; Kaufman, J; Dahl, R; Perel, J; and Nelson, B. Childhood and adolescent depression: A review of the past 10 years - Part I. J. Am. Acad. Child Adolesc. Psychiatry 35:1427-1439, 1996b.
6. Birmaher, B; Waterman, S; Ryan, N; et al. A randomized, controlled trial of amitriptyline versus placebo for adolescents with "treatment-resistant" major depression. J. Am. Acad. Child Adolesc. Psychiatry, in press.
7. Brent, DA; Holder, D; Kolko, D; Birmaher, B; Baugher, M; Roth, C; Iyengar, S; and Johnson, B. A clinical psychotherapy trial for adolescent depression comparing cognitive, family, and supportive treatments. Arch. Gen. Psychiatry 54:877-885, 1997.
8. Brent, DA; Poling, K; McKain, B; and Baugher, MA. Psychoeducational program for families of affectively ill children and adolescents. J. Am. Acad. Child Adolesc. Psychiatry 32(4):770-774, 1993.
9. Brown, RA, and Lewinsohn, PM. A psychoeducational approach to the treatment of depression: Comparison of group, individual and minimal contact procedures. J. Consult. Clin. Psychol. 52:774-783, 1984.
10. Clarke, GN; Hawkins, W; Murphy, M; Sheeber, LB; Lewinsohn, PM; and Seeley, JR. Targeted prevention of unipolar depressive disorder in an at-risk sample of high school adolescents: A randomized trial of a group cognitive intervention. J. Am. Acad. Child Adolesc Psychiatry 34:312-321, 1995.
11. Clein, PD, and Riddle, MA. Pharmacokinetics in children and adolescents. Child Adolesc. Psychiatr. Clin. North Am. 4(1):59-75, 1995.
12. Emslie, G; Rush, AJ; Weinberg, AW; Kowatch, RA; Hughes, CW; Carmody, T; and Rintelmann, J. A double-blind, randomized placebo-controlled trial of fluoxetine in children and adolescents with depression. Arch. Gen. Psychiatry 54(11):1031-1037, 1997.
13. Fine, S; Forth, A; Gilbert, M; and Haley, G. Group therapy for adolescent depressive disorder: A comparison of social skills and therapeutic support. J. Am. Acad. Child Adolesc. Psychiatry 30:79-85, 1991.
14. Frank, E; Kupfer, DJ; Perel, JM; Comes, C; Jarrett, DB; Mallinger, AG; Thase, ME; McEachran, AB; and Grochocinski, VJ. Three-year outcomes for maintenance therapies in recurrent depression. Arch. Gen. Psychiatry 47:1093-1099, 1990.
15. Frank, E; Kupfer, DJ; Perel, JM; Cornes, C; Mallinger, AG; Thase, ME; McEachran, AB; and Grochocinski, VJ. Comparison of full dose versus half dose pharmacotherapy in the maintenance treatment of recurrent depression. J. Affect. Disord. 27:139-145, 1993.
16. Geller, B; Cooper, T; Graham, D; Marsteller, FA; and Bryant, DM. Double-blind placebo-controlled study of nortriptyline in depressed adolescents using a "fixed plasma level" design. Psychopharmacol. Bull. 26:85-90, 1990.
17. Geller, B; Cooper, T; McCombs, H; Graham, D; and Wells, J. Double-blind, placebo-controlled study of nortriptyline in depressed children using a "fixed plasma level" design. Psychopharmacol. Bull. 25:101-108, 1989.
18. Gershon, ES; Hamovitt, JH; Guroff, JJ; and Nurnberger, JI. Birth-cohort changes in manic and depressive disorders in relatives of bipolar and schizoaffective patients. Arch. Gen. Psychiatry 44:314-319, 1987.
19. Goldman-Rakic, PS, and Brown, RM. Regional changes of monoamines in cerebral cortex and subcortical structures of aging rhesus monkeys. Neuroscience 6:177-187, 1981.
20. Hamilton, M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 23:56-61, 1960.
21. Hughes, CW; Preskorn, SH; Wrona, M; Hassanein, R; and Tucker, S. Followup of adolescents initially treated for prepubertal-onset major depressive disorder with imipramine. Psychopharmacol. Bull. 26(2):244-248, 1990.
22. Jaycox, LH; Reivich, KJ; Gillham, J; and Seligman, MEP. The prevention of depressive symptoms in school children. Behav. Res. Ther. 32:801-816, 1994.
23. Kahn, JS; Kehle, TJ; Jenson, WR; and Clark, E. Comparison of cognitive-behavioral, relaxation, and self-modeling interventions for depression among middle-school students. School Psychol. Rev. 19:196-211, 1990.
24. Kashani, J; Shekim, W; and Reid, J. Amitriptyline in children with major depressive disorder: A double-blind crossover pilot study. J. Am. Acad. Child Adolesc. Psychiatry 23:348-351, 1984.
25. Klein, R, and Koplewicz, H. "Despiramine Treatment in Adolescent Depression." Presented at the Child Depression Consortium Meeting, Pittsburgh, PA, September 1990.
26. Kovacs, M; Akiskal, S; Gatsonis, C; and Parrone, PL. Childhood-onset dysthymic disorder. Arch. Gen. Psychiatry 51:365-374, 1994.
27. Kovacs, M; Feinberg, TL; Crouse-Novak, MA; Paulaskas, SL; and Finkelstein, R. Depressive disorders in childhood. I. A longitudinal study of characteristics and recovery. Arch. Gen. Psychiatry 41:229-237, 1984a.
28. Kovacs, M; Feinberg, TL; Crouse-Novak, M; Paulaskas, SL; Pollock, M; and Finkelstein, R. Depressive disorders in childhood. II. A longitudinal study of the risk for a subsequent major depression. Arch. Gen. Psychiatry 41:643-649, 1984b.
29. Kovacs, M, and Gatsonis, C. Secular trends in age at onset of major depressive disorder in a clinical sample of children. J. Psychiatr. Res. 28:319-329, 1994.
30. Kramer, A, and Feiguine, R. Clinical effects of amitriptyline in adolescent depression. J. Am. Acad. Child Psychiatry 20:636-644, 1981.
31. Kroll, L; Harrington, R; Jayson, D; Fraser, J; and Gowers, S. Pilot study of continuation cognitive-behavioral therapy for major depression in adolescent psychiatric patients. J. Am. Acad. Child Adolesc. Psychiatry 35:1156-1161, 1996.
32. Kupfer, D; Frank, E; and Perel, J. Five-year outcome for maintenance therapies in recurrent depression. Arch. Gen. Psychiatry 49:769-773, 1992.
33. Kutcher, S; Boulos, C; Ward, B; Marton, P; Simeon, J; Ferguson, HB; Szalai, J; Katic, M; Roberts, N; and Dubois, C. Response to desipramine treatment in adolescent depression: A fixed dose, placebo-controlled trial. J. Am. Acad. Child Adolesc. Psychiatry 33:686-694, 1994.
34. Kye, C, and Ryan, ND. Pharmacologic treatment of child and adolescent depression. Child Adolesc. Clin. North Am. 4:261-281, 1995.
35. Kye, C; Waterman, GS; Ryan, ND; Birmaher, B; Williams, DE; Iyengar, S; and Dachille, S. Randomized control trial of amitripty-line in the acute treatment of adolescent major depression. J. Am. Acad. Child Adolesc. Psychiatry 35:1139-1144, 1996.
36. Lavori, PW; Klerman, GL; Keller, MB; Reich, T; Rice, J; and Endicott, J. Age-period-cohort analysis of secular trends in onset of major depressions: Findings in siblings of patients with major affective disorder. J. Psychiatr. Resid. 21:23-35, 1987.
37. Mandoki, MW; Tapia, MR; Tapia, MA; Sumner, GS; and Parker, JL. Venlafaxine in the treatment of children and adolescents with major depression. Psychopharmacol. Bull. 33(1):149-154, 1997.
38. Petti, T, and Law, W. Imipramine treatment of depressed children: A double-blind pilot study. J. Clin. Psychopharmacol. 2:107-110, 1982.
39. Preskorn, SH; Weller, EB; Hughes, CW; Weller, RA; and Bolte, K. Depression in prepubertal children: Dexamethasone nonsuppression predicts differential response to imipramine vs. placebo. Psychopharmacol. Bull. 23:128-133, 1987.
40. Prien, RF, and Kocsis, JH. Long-term treatment of mood disorders. In: Bloom, FE, and Kupfer, DJ, eds. Psychopharmacology: The Fourth Generation of Progress. New York: Raven Press, 1995. pp. 1067-1079.
41. Puig-Antich, J; Perel, J; Lupatkin, W; Chambers, WJ; Tabrizi, MA; King, J; Goetz, R; Davies, M; and Stiller, RL. Imipramine in prepubertal major depressive disorders. Arch. Gen. Psychiatry 44:81-89, 1987.
42. Rao, U; Ryan, ND; and Birmaher, B. Unipolar depression in adolescence: Clinical outcome in adulthood. J. Am. Acad. Child Adolesc. Psychiatry 34:566-578, 1995.
43. Ryan, ND; Williamson, DE; Iyengar, S; Orvaschel, H; Reich, T; Dahl, RE; and Puig-Antich, J. A secular increase in child and adolescent onset affective disorder. J. Am. Acad. Child Adolesc. Psychiatry 31:600-605, 1992.
44. Simeon, J; Dinicola, V; Ferguson, H; and Copping, W. Adolescent depression: A placebo-controlled fluoxetine treatment study and follow-up. Prog. Neuropsychopharmacol. Biol. Psychiatry 14:791-795, 1990.
45. Stark, KD; Reynolds, WM; and Kaslow, NJ. A comparison of the relative efficacy of self-control therapy and a behavioral problem-solving therapy for depression in children. J. Abnorm. Child Psychol. 15:91-113, 1987.
46. Swedo, S; Allen, AJ; Glod, CA; Clark, CH; Teicher, MH; Richter, D; Hoffman, C; Hamburger, SD; Dow, S; Brown, C; and Rosenthal, NE. A controlled trial of light therapy for the treatment of pediatric seasonal affective disorder. J. Am. Acad. Child Adolesc. Psychiatry 36(6):816-821, 1997.
47. Vostanis, P; Feehan, C; Grattan, E; and Bickerton, WA. A randomized controlled outpatient trial of cognitive-behavioral treatment for children and adolescents with depression: 9-Month follow-up. J. Affect. Disord. 40:105-116, 1996.
48. Wood, A; Harrington, R; and Moore, A. Controlled trial of a brief cognitive-behavioral intervention in adolescent patients with depressive disorders. J. Child Psychol. Psychiatry 37:737-746, 1996.